Xu X, An Q, Zhang J, Tang P, Cheng S
Department of Otorhinolaryngology Head and Neck Surgery, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China.
Zhonghua Er Bi Yan Hou Ke Za Zhi. 2001 Oct;36(5):367-71.
Loss of heterozygosity (LOH) studies indicate that allelic loss associated with the development of head and neck of squamous cell carcinoma occurs most frequently at 9p21-22. However, the target of chromosome 9p21-22 loss has been the source of significant debate. A putative tumor suppressor gene, p16, has been identified at the 9p21 location, but genetic alterations of p16 located in this region are unusual. To refine the hot spots of LOH on chromosome 9p13-23 will be helpful to find other putative tumor suppressor genes in laryngeal squamous cell carcinoma.
The sections of paraffin-embedded tumor tissues were microdissected to enrich for neoplastic cells. LOH on 9p13-23 was analyzed in a set of 42 paired blood and tumor samples using polymerase chain reaction (PCR) with 13 highly polymorphic microsatellite markers.
Of the 42 total tumors, 41(97.6%) showed LOH in at least one of the microsatellite markers tested at the chromosome 9p13-23 region. The most frequently deleted marker was D9S162 with in 17 of 19 (89.5%) informative samples. The marker D9S171, which is located in 9p21, had LOH detected in 12 of 15 informative cases (80.0%). LOH at the D9S1748 marker (closest to the p16 gene locus) was detected in 18 of 36 informative cases (50.0%). Fine deletion mapping also revealed two minimal regions of LOH encompassing markers D9S161-D9S171 at 9p21 and IFNA-D9S162 at 9p22-23.
These findings imply the high frequency of LOH at 9p13-23 in laryngeal squamous cell carcinoma and the presence of at least two as yet unidentified tumor suppressor genes in 9p13-23 region. Those putative tumor suppressor genes may become inactivated during the progression of the laryngeal squamous cell carcinoma.
杂合性缺失(LOH)研究表明,与头颈部鳞状细胞癌发生相关的等位基因缺失最常发生在9p21 - 22区域。然而,9p21 - 22染色体区域缺失的靶点一直是激烈争论的焦点。在9p21位置已鉴定出一个假定的肿瘤抑制基因p16,但位于该区域的p16基因改变并不常见。细化9p13 - 23染色体上LOH的热点区域将有助于在喉鳞状细胞癌中找到其他假定的肿瘤抑制基因。
对石蜡包埋的肿瘤组织切片进行显微切割以富集肿瘤细胞。使用聚合酶链反应(PCR)和13个高度多态性微卫星标记,对42对血液和肿瘤样本进行9p13 - 23区域的LOH分析。
在42个肿瘤中,41个(97.6%)在9p13 - 23染色体区域测试的至少一个微卫星标记中显示出LOH。最常缺失的标记是D9S162,在19个信息性样本中的17个(89.5%)中出现缺失。位于9p21的标记D9S171,在15个信息性病例中的12个(80.0%)中检测到LOH。在36个信息性病例中的18个(50.0%)中检测到最接近p16基因座的D9S1748标记处的LOH。精细缺失图谱还揭示了两个最小的LOH区域,一个包含9p21处的标记D9S161 - D9S171,另一个包含9p22 - 23处的IFNA - D9S162。
这些发现表明喉鳞状细胞癌中9p13 - 23区域LOH的频率很高,并且在9p13 - 23区域存在至少两个尚未鉴定的肿瘤抑制基因。那些假定的肿瘤抑制基因可能在喉鳞状细胞癌进展过程中失活。